| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
36 Accelerated hypofractionated radical radiotherapy for non-small cell lung cancer: A single centre audit of outcome using 55 Gy in 20 daily fractions
|
Pemberton, L.S.
|
|
2007
|
57 |
S1 |
p. S10-
1 p.
|
artikel
|
| 2 |
77 Active treatment rate for lung cancer patients in the South of Manchester: are we doing enough?
|
Devbhandari, M.P.
|
|
2007
|
57 |
S1 |
p. S21-
1 p.
|
artikel
|
| 3 |
21 Adjuvant chemotherapy in Non Small Cell Lung Cancer (NSCLC) —a feasibility study in the non-trial population
|
Treece, S.J.
|
|
2007
|
57 |
S1 |
p. S6-
1 p.
|
artikel
|
| 4 |
52 Adjuvant radiotherapy (RT) following extra-pleural pneumonectomy (EPP)—the Guys & St Thomas experience
|
Miah, A.
|
|
2007
|
57 |
S1 |
p. S14-
1 p.
|
artikel
|
| 5 |
72 A lung cancer/mesothelioma patient information —a network wide quality driven project
|
Burgoyne, A.
|
|
2007
|
57 |
S1 |
p. S20-
1 p.
|
artikel
|
| 6 |
88 A national audit of the impact of telephone contact on the lung cancer nurse specialist service
|
Bell, N.
|
|
2007
|
57 |
S1 |
p. S24-
1 p.
|
artikel
|
| 7 |
86 An audit of lung cancer referrals detected during CT pulmonary angiogram (CTPA)
|
Evans, J.
|
|
2007
|
57 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 8 |
43 An audit of patients treated with concurrent chemoradiotherapy
|
Kelly, V.
|
|
2007
|
57 |
S1 |
p. S12-
1 p.
|
artikel
|
| 9 |
34 A retrospective review of a unique high dose palliative radiotherapy fractionation regime for locally advanced and metastatic lung cancer at Mount Vernon Hospital
|
Corner, C.
|
|
2007
|
57 |
S1 |
p. S10-
1 p.
|
artikel
|
| 10 |
54 A survey of the treatment of intervention sites in patients with malignant pleural mesothelioma with radiotherapy by oncologists in the British Isles
|
Waite, K.
|
|
2007
|
57 |
S1 |
p. S15-
1 p.
|
artikel
|
| 11 |
19 Audit of adjuvant chemotherapy for non small cell lung carcinoma
|
Aynsley, E.
|
|
2007
|
57 |
S1 |
p. S6-
1 p.
|
artikel
|
| 12 |
29 Audit to analyse the role of pre-treatment verification in 3D CT planning for NSCLC
|
Raj, S.
|
|
2007
|
57 |
S1 |
p. S8-
1 p.
|
artikel
|
| 13 |
Author index
|
|
|
2007
|
57 |
S1 |
p. S27-S29
3 p.
|
artikel
|
| 14 |
69 Blockade of neuropilin-1 decreases NSCLC survival by regulating angiogenic and apoptotic gene expression
|
Pidgeon, G.P.
|
|
2007
|
57 |
S1 |
p. S19-
1 p.
|
artikel
|
| 15 |
73 Can patients and carers have too many telephone contacts?
|
Underwood, I.
|
|
2007
|
57 |
S1 |
p. S20-
1 p.
|
artikel
|
| 16 |
13 Carboplatin dose calculation in lung cancer
|
Wheater, M.
|
|
2007
|
57 |
S1 |
p. S4-
1 p.
|
artikel
|
| 17 |
87 Community based smoking cessation project
|
Cronin, N.
|
|
2007
|
57 |
S1 |
p. S24-
1 p.
|
artikel
|
| 18 |
35 CONVERT-A multicentre randomised controlled NCRN trial comparing accelerated twice-daily and high dose once-daily thoracic radiotherapy in good performance status (PS), limited small-cell lung cancer (LD SCLC) treated concurrently with cisplatin and etoposide
|
Faivre-Finn, C.
|
|
2007
|
57 |
S1 |
p. S10-
1 p.
|
artikel
|
| 19 |
84 Dealing with the impact of surgery for lung cancer on the patient & their family
|
Devenay, S.
|
|
2007
|
57 |
S1 |
p. S23-
1 p.
|
artikel
|
| 20 |
85 Demographic and prognostic look at lung cancer patients in South East Eire
|
Quintyne, K.I.
|
|
2007
|
57 |
S1 |
p. S23-
1 p.
|
artikel
|
| 21 |
81 Development of education tools to help improve nurse education and patient management in the management of chemotherapy side effects
|
Brown, L.
|
|
2007
|
57 |
S1 |
p. S22-
1 p.
|
artikel
|
| 22 |
79 Diagnostic delay in lung cancer: a qualitative study
|
Tod, A.M.
|
|
2007
|
57 |
S1 |
p. S22-
1 p.
|
artikel
|
| 23 |
31 Dose-individualisation for lung cancer radiotherapy —are we ready?
|
Malik, Z.
|
|
2007
|
57 |
S1 |
p. S9-
1 p.
|
artikel
|
| 24 |
Editorial board
|
|
|
2007
|
57 |
S1 |
p. iii-
1 p.
|
artikel
|
| 25 |
30 Effect of calculation algorithms on dose prescription and planning for lung radiotherapy
|
McNee, S.G.
|
|
2007
|
57 |
S1 |
p. S8-S9
2 p.
|
artikel
|
| 26 |
6 Endobronchial and endoscopic ultrasound for assessment of PET positive mediastinal lymph nodes
|
Rintoul, R.C.
|
|
2007
|
57 |
S1 |
p. S2-
1 p.
|
artikel
|
| 27 |
14 Evaluation of patient preference for oral or intravenous vinorelbine in the treatment of non small cell lung and breast cancer
|
Shaw, A.
|
|
2007
|
57 |
S1 |
p. S4-
1 p.
|
artikel
|
| 28 |
25 FRAGMATIC. A randomised phase III clinical trial investigating the effect of FRAGMin® added to standard therapy in patients with lung cancer
|
Macbeth, F.
|
|
2007
|
57 |
S1 |
p. S7-
1 p.
|
artikel
|
| 29 |
70 Framework to guide lung cancer MDTs in the Yorkshire Cancer Network (YCN) in the support and follow up of patients with lung cancer by the Lung Cancer Nurse Specialist (LCNS)
|
White, J.
|
|
2007
|
57 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 30 |
65 Hypoxia, phosphoAkt cellular localization and cell survival
|
Gately, K.
|
|
2007
|
57 |
S1 |
p. S18-
1 p.
|
artikel
|
| 31 |
71 Improving knowledge of lung cancer using the cancer specialist library
|
Peake, M.
|
|
2007
|
57 |
S1 |
p. S20-
1 p.
|
artikel
|
| 32 |
32 Improving outcomes for radical radiotherapy in T1–2N0–1 medically inoperable non-small cell lung cancer (NSCLC); Northern Ireland experience 2001–2004
|
McAleese, J.
|
|
2007
|
57 |
S1 |
p. S9-
1 p.
|
artikel
|
| 33 |
39 INCH: induction chemotherapy & CHART in non-small cell lung cancer
|
Hatton, M.
|
|
2007
|
57 |
S1 |
p. S11-
1 p.
|
artikel
|
| 34 |
60 Insulin receptor substrate 5 (IRS-5). Its regulation and altered expression in cancer
|
Al-Sarraf, N.
|
|
2007
|
57 |
S1 |
p. S17-
1 p.
|
artikel
|
| 35 |
64 Intracytoplasmic inclusion bodies in lung cancer specimens treated with transthyretin antibodies
|
Hatfield, B.
|
|
2007
|
57 |
S1 |
p. S18-
1 p.
|
artikel
|
| 36 |
82 Introduction of nurse-led follow-up information & support clinic for lung cancer patients
|
Featonby, P.
|
|
2007
|
57 |
S1 |
p. S22-S23
2 p.
|
artikel
|
| 37 |
89 Is contact and intervention from the specialist Lung Cancer Nurse of benefit to patients and carers at the investigation stage?
|
Haslop, C.
|
|
2007
|
57 |
S1 |
p. S24-
1 p.
|
artikel
|
| 38 |
40 Isotoxic hypofractionated radical radiotherapy for non-small cell lung cancer
|
Wills, L.
|
|
2007
|
57 |
S1 |
p. S11-
1 p.
|
artikel
|
| 39 |
2 Is the whole body PET/CT scan a luxury procedure for investigating pulmonary lesions compared to a thoracic and upper abdominal study?
|
Winship, A.
|
|
2007
|
57 |
S1 |
p. S1-
1 p.
|
artikel
|
| 40 |
20 Labour pains in the birth of adjuvant chemotherapy
|
Pollock, R.
|
|
2007
|
57 |
S1 |
p. S6-
1 p.
|
artikel
|
| 41 |
10 Lung sequestration and foregut cyst misleading staging investigations for colonic cancer. A case report
|
Tregay, N.
|
|
2007
|
57 |
S1 |
p. S3-
1 p.
|
artikel
|
| 42 |
45 Measured alterations in pulmonary function after radical accelerated hypofractionated radiotherapy concurrent with cisplatinum and vinorelbine: safety of SOCCAR experimental regimen
|
Maguire, J.
|
|
2007
|
57 |
S1 |
p. S12-
1 p.
|
artikel
|
| 43 |
68 Mechanisms controlling survival and induction of apoptosis following 12-lipoxygenase (LOX) inhibition in non small cell lung cancer (NSCLC)
|
Campbell, V.
|
|
2007
|
57 |
S1 |
p. S19-
1 p.
|
artikel
|
| 44 |
67 Mechanisms regulating thromboxane synthase in the pathogenesis of lung cancer: a potential target for therapeutic intervention
|
Cathcart, M.C.
|
|
2007
|
57 |
S1 |
p. S18-S19
2 p.
|
artikel
|
| 45 |
90 Mesothelioma MDT — initial experience of a regional model
|
Duckers, J.
|
|
2007
|
57 |
S1 |
p. S25-
1 p.
|
artikel
|
| 46 |
57 Mesothelioma UK: the development of a mesothelioma resource centre
|
Darlison, A.E.
|
|
2007
|
57 |
S1 |
p. S16-
1 p.
|
artikel
|
| 47 |
63 Neuropilin-1 blockade inhibits hypoxia-induced Akt and MAPK phosphorylation and induces apoptosis of non-small cell lung cancer cells
|
Barr, M.P.
|
|
2007
|
57 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 48 |
74 Northern cancer network lung audit — outcome data: 1999–2004
|
Peel, T.
|
|
2007
|
57 |
S1 |
p. S20-
1 p.
|
artikel
|
| 49 |
44 Oesophagitis after concurrent ChemoRT using accelerated hypofractionated radiotherapy with cisplatinum and vinorelbine
|
Maguire, J.
|
|
2007
|
57 |
S1 |
p. S12-
1 p.
|
artikel
|
| 50 |
15 Oral vinorelbine in combination with carboplatin for the treatment of inoperable non-small cell lung cancer (NSCLC) —the Kent Experience
|
Raman, R.
|
|
2007
|
57 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 51 |
24 Outcomes with erlotinib (Tarceva®) in a Yorkshire cancer centre
|
O'Toole, L.
|
|
2007
|
57 |
S1 |
p. S7-
1 p.
|
artikel
|
| 52 |
17 Outreach chemotherapy: convenience versus quality?
|
Danson, S.
|
|
2007
|
57 |
S1 |
p. S5-
1 p.
|
artikel
|
| 53 |
38 Pattern of recurrence after continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer
|
Din, O.
|
|
2007
|
57 |
S1 |
p. S11-
1 p.
|
artikel
|
| 54 |
53 Pemetrexed based chemotherapy for malignant mesothelioma; a retrospective analysis of 100 consecutively treated patients
|
Taylor, P.D.
|
|
2007
|
57 |
S1 |
p. S15-
1 p.
|
artikel
|
| 55 |
37 Phase I/II clinical trial of accelerated hypofractionated radiation schedule for non small cell lung cancer
|
Fitzpatrick, D.
|
|
2007
|
57 |
S1 |
p. S10-
1 p.
|
artikel
|
| 56 |
22 Phase II pilot study of neoadjuvant cetuximab in combination with cisplatin and gemcitabine in patients with resectable 1B-IIIA non-small-cell lung cancer: preliminary results
|
Coate, L.
|
|
2007
|
57 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 57 |
42 Post operative radiotherapy and microscopic disease at the bronchial margin for non-small cell lung cancer (NSCLC); audit of 4 years data from the Northern Ireland Cancer Centre
|
Wilson, J.
|
|
2007
|
57 |
S1 |
p. S12-
1 p.
|
artikel
|
| 58 |
55 Prophylactic radiotherapy to intervention sites in mesothelioma
|
Lee, C.
|
|
2007
|
57 |
S1 |
p. S15-
1 p.
|
artikel
|
| 59 |
66 Prostacyclin synthase (PTGIS): Expression and epigenetic regulation in lung cancer
|
Cathcart, M.C.
|
|
2007
|
57 |
S1 |
p. S18-
1 p.
|
artikel
|
| 60 |
8 Pulmonary resection for metastatic colorectal cancer
|
Kirk, A.J.B.
|
|
2007
|
57 |
S1 |
p. S3-
1 p.
|
artikel
|
| 61 |
33 Radical radiotherapy for non small cell lung cancer (NSCLC): can chemotherapy make the untreatable treatable?
|
Hudson, E.
|
|
2007
|
57 |
S1 |
p. S9-S10
2 p.
|
artikel
|
| 62 |
28 Safety study of sequential and synchronous chemoradiotherapy (CRT) and Cetuximab in Stage III non-small cell lung cancer (NSCLC): SCRATCH
|
Hughes, S.
|
|
2007
|
57 |
S1 |
p. S8-
1 p.
|
artikel
|
| 63 |
48 Should surgical resection be considered in selected cases of small cell lung cancer?
|
Soon, S.Y.
|
|
2007
|
57 |
S1 |
p. S13-
1 p.
|
artikel
|
| 64 |
50 Single stage video assisted cervical thoracomediastinoscopy (VACTM) for diagnosis, staging and pleurodesis of malignant pleural mesothelioma
|
Chamberlain, M.H.
|
|
2007
|
57 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 65 |
46 Small cell lung cancer: 8 year experience of a single multidisciplinary team
|
El-Helw, L.
|
|
2007
|
57 |
S1 |
p. S12-S13
2 p.
|
artikel
|
| 66 |
76 Social and geographical factors that affect the outcome of patients with lung cancer
|
Crawford, S.M.
|
|
2007
|
57 |
S1 |
p. S21-
1 p.
|
artikel
|
| 67 |
7 Staging and survival in non-small cell lung cancer using simple blood parameters
|
McGonigle, N.C.
|
|
2007
|
57 |
S1 |
p. S2-
1 p.
|
artikel
|
| 68 |
47 Surgery as primary treatment for small cell lung cancer: time to re-evaluate
|
Lim, E.
|
|
2007
|
57 |
S1 |
p. S13-
1 p.
|
artikel
|
| 69 |
11 Surgical resection after radical accelerated hypofractionated radiotherapy concurrent with cisplatinum/vinorelbine for initially inoperable NSCLC
|
Maguire, J.
|
|
2007
|
57 |
S1 |
p. S3-
1 p.
|
artikel
|
| 70 |
9 Surgical resection for lung cancer in the elderly; is it worth the effort?
|
Kirk, A.J.B.
|
|
2007
|
57 |
S1 |
p. S3-
1 p.
|
artikel
|
| 71 |
56 Survival and treatment of mesothelioma cases in Sheffield, UK from Sep 1998 to Mar 2006
|
Chaudhuri, N.
|
|
2007
|
57 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 72 |
58 Talc pleurodesis: doctor versus nurse led procedure —a prospective, randomised, multi-centre, pilot study
|
Munday, H.
|
|
2007
|
57 |
S1 |
p. S16-
1 p.
|
artikel
|
| 73 |
80 The changing faces of lung cancer patient pathway
|
Underwood, I.
|
|
2007
|
57 |
S1 |
p. S22-
1 p.
|
artikel
|
| 74 |
49 The changing pattern of diagnostic investigations for mesothelioma
|
Ohri, C.M.
|
|
2007
|
57 |
S1 |
p. S13-
1 p.
|
artikel
|
| 75 |
1 The clinical impact of positron emission tomography (PET) scanning on the staging and management of non small cell lung cancer (NSCLC)
|
Mackay, A.J.
|
|
2007
|
57 |
S1 |
p. S1-
1 p.
|
artikel
|
| 76 |
5 The contribution of transbronchial needle aspiration (TBNA) to lung cancer staging — a four-year experience
|
Thomas, C.
|
|
2007
|
57 |
S1 |
p. S2-
1 p.
|
artikel
|
| 77 |
78 The effect of chest CT scanning prior to first appointment on the time to treatment for lung cancer patients
|
Hill, J.M.
|
|
2007
|
57 |
S1 |
p. S21-S22
2 p.
|
artikel
|
| 78 |
4 The effect of routine preoperative CT-PET staging on the results of surgical resection of non-small cell lung cancer
|
Ong, S.L.
|
|
2007
|
57 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 79 |
23 The financial onus of Erlotinib: Is it really more expensive?
|
Abdul Razak, A.R.
|
|
2007
|
57 |
S1 |
p. S7-
1 p.
|
artikel
|
| 80 |
59 The mesothelioma and radical surgery (MARS) trial update
|
Duffy, N.
|
|
2007
|
57 |
S1 |
p. S16-S17
2 p.
|
artikel
|
| 81 |
75 The national lung cancer audit: highlights from the first annual report
|
Chanarin, N.
|
|
2007
|
57 |
S1 |
p. S21-
1 p.
|
artikel
|
| 82 |
41 The QUARTZ Trial: Quality of life after radiotherapy and steroids in patients with inoperable brain metastases from non-small cell lung cancer
|
Moore, B.
|
|
2007
|
57 |
S1 |
p. S11-
1 p.
|
artikel
|
| 83 |
62 The role of IL-20 in lung cancer-a new epigenetic target?
|
Baird, A.M.
|
|
2007
|
57 |
S1 |
p. S17-
1 p.
|
artikel
|
| 84 |
51 The role of VATS Decortication in the therapeutic management of Malignant Pleural Mesothelioma (MPM)
|
Nakas, A.
|
|
2007
|
57 |
S1 |
p. S14-
1 p.
|
artikel
|
| 85 |
61 The VEGF signalling pathway and the chromatin environment in lung cancer
|
Al-Sarraf, N.
|
|
2007
|
57 |
S1 |
p. S17-
1 p.
|
artikel
|
| 86 |
83 Thoracic surgical liaison in lung cancer: developing a role in the patient journey
|
Cunningham, A.
|
|
2007
|
57 |
S1 |
p. S23-
1 p.
|
artikel
|
| 87 |
16 Transfusion costs associated with use of Gemcitabine-Carboplatin in the treatment of incurable non small cell lung cancer (NSCLC)
|
Abdul Razak, A.R.
|
|
2007
|
57 |
S1 |
p. S5-
1 p.
|
artikel
|
| 88 |
27 UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLC) —DEAL-RT
|
Hughes, S.
|
|
2007
|
57 |
S1 |
p. S8-
1 p.
|
artikel
|
| 89 |
18 Use of adjuvant chemotherapy in resected early stage NSCLC in Grampian
|
Brown, L.
|
|
2007
|
57 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 90 |
3 Use of PET in management of early stage non-small cell lung cancer in Grampian
|
Kennedy, A.M.
|
|
2007
|
57 |
S1 |
p. S1-
1 p.
|
artikel
|
| 91 |
12 Would using Wright formula to calculate GFR reduce toxicity in palliative chemotherapy for patients with non-small cell lung cancer (NSCLC)?
|
Bedi, C.
|
|
2007
|
57 |
S1 |
p. S4-
1 p.
|
artikel
|
| 92 |
26 X-ray volumetric imaging (XVI) to quantitate the dosimetric impact of the uncertainties during radical radiotherapy (RT) of non small cell lung cancers
|
Jain, P.
|
|
2007
|
57 |
S1 |
p. S7-S8
2 p.
|
artikel
|
Tijdschrift beschrijving